Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of Toreforant (JNJ-38518168) in participants with moderate-to-severe plaque-type psoriasis; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Toreforant (JNJ-38518168)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED